Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ATAMG (Advanced Therapy Advisory and Management Group) is a specialized consultancy firm providing strategic, technical, and operational support to the advanced therapy sector, specifically focusing on cell and gene therapies. The company assists biotechnology firms, academic institutions, and investors in navigating the complex development, manufacturing, and commercialization pathways for Advanced Therapy Medicinal Products (ATMPs). Led by industry veterans with extensive experience in global pharmaceutical leadership, ATAMG offers services ranging from clinical development strategy and regulatory affairs to supply chain optimization and market access. The firm plays a critical role in the ecosystem by bridging the gap between early-stage scientific innovation and large-scale commercial delivery of transformative medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ATAMG.